[1]
R. S. Singh, S. S. Ingle, and M. R. Dehankar, “Comparative glycemic efficacy and safety of sitagliptin versus gliclazide in uncomplicated type 2 diabetes mellitus: a 6-month prospective study ”, Int J Basic Clin Pharmacol, vol. 15, no. 4, pp. 718–722, Jun. 2026.